109 related articles for article (PubMed ID: 25345265)
1. The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease.
Wangkaew S; Euathrongchit J; Patiwetwitoon S; Prasertwitayakij N; Kasitanon N; Louthrenoo W
J Med Assoc Thai; 2014 Aug; 97(8):878-85. PubMed ID: 25345265
[TBL] [Abstract][Full Text] [Related]
2. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
[TBL] [Abstract][Full Text] [Related]
3. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.
Kim GHJ; Tashkin DP; Lo P; Brown MS; Volkmann ER; Gjertson DW; Khanna D; Elashoff RM; Tseng CH; Roth MD; Goldin JG
Arthritis Rheumatol; 2020 Feb; 72(2):316-325. PubMed ID: 31430058
[TBL] [Abstract][Full Text] [Related]
4. Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease.
Junfei Z; Meihua G; Shuai Z; Xiangting L; Zhidan L; Tianming C; Yajing L; Chu T; Lipu S
Clin Rheumatol; 2023 Oct; 42(10):2823-2832. PubMed ID: 37335409
[TBL] [Abstract][Full Text] [Related]
5. Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis.
Sivova N; Launay D; Wémeau-Stervinou L; De Groote P; Remy-Jardin M; Denis G; Lambert M; Lamblin N; Morell-Dubois S; Fertin M; Lefevre G; Sobanski V; Le Rouzic O; Hatron PY; Wallaert B; Hachulla E; Perez T
PLoS One; 2013; 8(10):e78001. PubMed ID: 24205063
[TBL] [Abstract][Full Text] [Related]
6. Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease in Brazil: A Real-Life, Long-Term Follow-up Observational Study.
de Oliveira Martins LV; Oliveira SM; Silvatti J; de Amorim FG; Agapito Tito CV; Kayser C
J Clin Rheumatol; 2022 Mar; 28(2):e532-e538. PubMed ID: 34609336
[TBL] [Abstract][Full Text] [Related]
7. The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis.
Gutierrez M; Bertolazzi C; Zozoaga-Velazquez E; Clavijo-Cornejo D
Tomography; 2024 Apr; 10(4):521-532. PubMed ID: 38668398
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary manifestations and prognosis of a cohort of patients with interstitial lung disease and positive to anti-Th/To autoantibodies.
Mejía M; Ramos-Martínez E; Vázquez-Becerra LE; Fernández-Badillo D; Mateos-Toledo HN; Castillo J; Estrada A; Rojas-Serrano J
Med Clin (Barc); 2024 Apr; 162(8):378-384. PubMed ID: 38290874
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension.
Çoksevim M; Çerik İB; Yenerçağ M; Kocasarı AO; Yavuzbilge G; Polat M; Meriç M; Özgen M
Int J Cardiovasc Imaging; 2022 Oct; 38(10):2191-2197. PubMed ID: 37726465
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis.
Le Gall A; Hoang-Thi TN; Porcher R; Dunogué B; Berezné A; Guillevin L; Le Guern V; Cohen P; Chaigne B; London J; Groh M; Paule R; Chassagnon G; Vakalopoulou M; Dinh-Xuan AT; Revel MP; Mouthon L; Régent A
Rheumatology (Oxford); 2024 Jan; 63(1):103-110. PubMed ID: 37074923
[TBL] [Abstract][Full Text] [Related]
11. Detection and classification of systemic sclerosis-related interstitial lung disease: a review.
DeMizio DJ; Bernstein EJ
Curr Opin Rheumatol; 2019 Nov; 31(6):553-560. PubMed ID: 31415029
[TBL] [Abstract][Full Text] [Related]
12. Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study.
Mohammad Reza Beigi D; Pellegrino G; Loconte M; Landini N; Mattone M; Paone G; Truglia S; Di Ciommo FR; Bisconti I; Cadar M; Stefanantoni K; Panebianco V; Conti F; Riccieri V
Rheumatology (Oxford); 2024 May; 63(5):1240-1245. PubMed ID: 37399086
[TBL] [Abstract][Full Text] [Related]
13. Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
Hoffmann-Vold AM; Weigt SS; Palchevskiy V; Volkmann E; Saggar R; Li N; Midtvedt Ø; Lund MB; Garen T; Fishbein MC; Ardehali A; Ross DJ; Ueland T; Aukrust P; Lynch JP; Elashoff RM; Molberg Ø; Belperio JA
PLoS One; 2018; 13(11):e0206545. PubMed ID: 30457999
[TBL] [Abstract][Full Text] [Related]
14. Management of Systemic-Sclerosis-Associated Interstitial Lung Disease.
Silver KC; Silver RM
Rheum Dis Clin North Am; 2015 Aug; 41(3):439-57. PubMed ID: 26210128
[TBL] [Abstract][Full Text] [Related]
15. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
Mismetti V; Delavenne X; Montani D; Bezzeghoud S; Delezay O; Hodin S; Launay D; Marchand-Adam S; Nunes H; Ollier E; Reynaud-Gaubert M; Pastre J; Traclet J; Quetant S; Zeghmar S; Bertoletti L; Cottin V
Respir Res; 2023 Nov; 24(1):273. PubMed ID: 37936223
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States.
Fan Y; Bender S; Shi W; Zoz D
J Manag Care Spec Pharm; 2020 Dec; 26(12):1539-1547. PubMed ID: 32996805
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes.
Kanski M; Arheden H; Wuttge DM; Bozovic G; Hesselstrand R; Ugander M
J Cardiovasc Magn Reson; 2013 Sep; 15(1):86. PubMed ID: 24066703
[TBL] [Abstract][Full Text] [Related]
18. Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study.
Hirose H; Higuchi T; Takagi K; Tochimoto A; Ichimura Y; Katsumata Y; Harigai M; Kawaguchi Y
Int J Rheum Dis; 2024 Jan; 27(1):e14978. PubMed ID: 37983908
[TBL] [Abstract][Full Text] [Related]
19. Development and Assessment of Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis.
Fairchild R; Chung M; Yang D; Sharpless L; Li S; Chung L
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1338-1342. PubMed ID: 32475026
[TBL] [Abstract][Full Text] [Related]
20. Type 2 cytokines and scleroderma interstitial lung disease.
Pellicano C; Vantaggio L; Colalillo A; Pocino K; Basile V; Marino M; Basile U; Rosato E
Clin Exp Med; 2023 Nov; 23(7):3517-3525. PubMed ID: 37392249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
